- In the Economist, Dr. Ron Depinho, the new president of the M.D. Anderson Cancer Center, shares his plans for curing cancers.
- A genetic study explains chemoresistance in some colorectal cancer patients.
- Women who take antiestrogen supplements may decrease their risk for melanoma.
- Navitoclax, a new drug in phase I trials, has had impressive results against hard-to-treat Chronic Lymphocytic Leukemia.